The grades of nine Medical Devices stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an “A” (“strong buy”) or “B” overall (“buy”) rating.
Winner Medical Group (NASDAQ:WWIN) is making headway this week, with the company’s rating improving to an A (“strong buy”) from a B (“buy”) last week. Winner Medical Group engages in the research, development, manufacture, and marketing of cotton-base medical dressings and medical disposables. For more information, get Portfolio Grader’s complete analysis of WWIN stock.
This week, Sirona Dental Systems (NASDAQ:SIRO) pushes up from a B to an A rating. Sirona Dental Systems is a manufacturer of high-quality, technologically-advanced dental equipment, and is focused on developing, manufacturing and marketing innovative solutions for dentists around the world. For more information, get Portfolio Grader’s complete analysis of SIRO stock.
Conceptus (NASDAQ:CPTS) shows solid improvement this week. The company’s rating rises from a B to an A. Conceptus designs, develops, and markets minimally invasive devices for reproductive medical applications primarily in the United States, France, and rest of Europe. For more information, get Portfolio Grader’s complete analysis of CPTS stock.
This week, Spectranetics’ (NASDAQ:SPNC) ratings are up from a B last week to an A. The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system, many of which are used with its proprietary excimer laser system. Shares of SPNC have increased 7.8% over the past month, better than the 2.3% increase the Nasdaq has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of SPNC stock.
Cardiovascular Systems (NASDAQ:CSII) earns an A this week, jumping up from last week’s grade of B. Cardiovascular Systems focuses on developing and commercializing minimally invasive treatment solutions for vascular disease. Investors seem to agree with the upgraded status of the stock, and have pushed the stock up 7.9% over the past month. For more information, get Portfolio Grader’s complete analysis of CSII stock.
Abbott Laboratories (NYSE:ABT) gets a higher grade this week, advancing from a B last week to an A. Abbott Laboratories discovers, develops, manufactures, and sells health care products. The stock currently has a trailing PE Ratio of 9.10. For more information, get Portfolio Grader’s complete analysis of ABT stock.
Zimmer Holdings’ (NYSE:ZMH) grade is moving up to a B (“buy”) this week from last week’s C (“hold”). Zimmer Holdings designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants and other surgical products. Wall Street seems to agree with the upgrade and has propelled the stock up 5.5% over the past month. For more information, get Portfolio Grader’s complete analysis of ZMH stock.
Stryker Corp.’s (NYSE:SYK) ratings are looking better this week, moving up to a B from last week’s C. Stryker produces a variety of products in the medical technology sector. Investors have pushed the stock price up 7.2% over the past month. For more information, get Portfolio Grader’s complete analysis of SYK stock.
The rating of Becton Dickinson (NYSE:BDX) moves up this week, rising from a C to a B. Becton, Dickinson and Company is a global medical technology company engaged in the development, manufacture, and sale of medical devices, instrument systems, and reagents. Wall Street has pushed the stock higher by 7.5% over the past month. For more information, get Portfolio Grader’s complete analysis of BDX stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
